Cessation

August 15, 2026 National Stock Exchange of India Limited BSE Limited Plot No. C/1, “G” Block, Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai 400 051 Mumbai 400 001 Symbol: RPGLIFE Security Code: 532983 Dear Sirs /Madam, Sub: Resignation of Senior Management Personnel. Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Deepak Shukla, Chief Executive - API Business, has ceased to be a Senior Management Personnel of the Company, with effect from the close of business hours on August 14, 2026, consequent upon his appointment as Chief Executive Officer in capacity of Key Managerial Personnel of RPG Active Pharma Limited, a wholly-owned subsidiary of the Company with effect from August 15, 2026. The details as required pursuant to the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed herewith as ‘Annexure A’ and a letter of resignation received from Mr. Deepak Shukla is enclosed herewith as ‘Annexure B’. Kindly take the same on record. Thanking you, Yours faithfully, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary Encl.: as above Annexure - A Disclosure Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. Particulars Remarks 1 Reason for change viz. Appointment, Mr. Deepak Shukla Chief Executive - API Business Re-appointment, Resignation, has ceased to be a Senior Management Personnel Removal, Retirement, of the Company consequent upon his appointment Death or Otherwise; as Chief Executive Officer of RPG Active Pharma Limited, a wholly-owned subsidiary of the Company. 2 Date of Appointment/ Effective from close of business hours on August Reappointment/ 14, 2026. Cessation (as applicable) & term of Appointment/ Re- appointment 3 Brief Profile (in case of Not Applicable appointment) 4 Disclosure of relationships between Not Applicable Directors (in case of appointment of a Director).